Evolent Health (EVH) Depreciation & Amortization (CF) (2015 - 2026)

Evolent Health has reported Depreciation & Amortization (CF) for 12 years, with the latest figure at $21.6 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 10.4% year-over-year to $21.6 million; the trailing twelve-month figure through Mar 2026 stood at $113.3 million (changed 0.37% YoY), and the FY2025 full-year result was $115.9 million, down 2.13% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $21.6 million, down from $45.0 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $45.0 million in Q4 2025, with the low at $15.1 million in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $26.3 million, with a median of $29.3 million recorded in 2023.
• Year-over-year, Depreciation & Amortization (CF) surged 112.64% in 2023 and dropped 22.53% in 2025.
• Tracing EVH's Depreciation & Amortization (CF) over 5 years: stood at $19.8 million in 2022, then jumped by 49.65% to $29.6 million in 2023, then declined by 1.03% to $29.3 million in 2024, then soared by 53.73% to $45.0 million in 2025, then sank by 52.14% to $21.6 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $21.6 million (Q1 2026), $45.0 million (Q4 2025), and $23.6 million (Q3 2025), per Business Quant data.

Peer Comparison